Report on the EMA Workshop on clinical trial data and transparency

ISSN： 2047-4814

Source： Medical Writing, Vol.22, Iss.2, 2013-06, pp. : 124-127

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transparency and reproducibility in data analysis: the Prostate Cancer Prevention Trial

By Baker Stuart G. Darke Amy K. Pinsky Paul Parnes Howard L. Kramer Barnett S.

Biostatistics, Vol. 11, Iss. 3, 2010-07 ,pp. : 413-418

Oxford University Press

Access to resources Recommend Favorite

Analyzing incomplete longitudinal clinical trial data

By Molenberghs Geert Thijs Herbert Jansen Ivy Beunckens Caroline

Biostatistics, Vol. 5, Iss. 3, 2004-07 ,pp. : 445-464

Oxford University Press

Access to resources Recommend Favorite

Implications of clinical trial data sharing for medical writers

By Ross Joseph S.

Medical Writing, Vol. 22, Iss. 1, 2013-03 ,pp. : 45-49

Maney Publishing

Access to resources Recommend Favorite

Methodological aspects and the interpretation of clinical trial data: lessons from the TEAR trial

By Fleischmann Roy

British Journal of Rheumatology , Vol. 52, Iss. 3, 2013-03 ,pp. : 409-410

Oxford University Press

Access to resources Recommend Favorite

Hepatic Effects of Duloxetine-I: Non-Clinical and Clinical Trial Data

Current Drug Safety, Vol. 3, Iss. 2, 2008-05 ,pp. : 132-142

Bentham Science Publishers

Access to resources Recommend Favorite